This position statement outlines the role of TEVAR as a less invasive alternative to open surgery for thoracic aortic diseases.
Thoracic endovascular aortic repair (TEVAR) is an emerging treatment modality, which has been rapidly embraced by clinicians treating thoracic aortic disease Fundamentally, it is a far less invasive approach than open surgery and its availability and relative ease of application has changed and extended management options in thoracic aortic disease, including in those
Grabenwöger et al. (Fri,) studied this question.